The company was also allotted one of four Spotlight presentation slots, which is a novelty to this year's programme and described as "Designed to showcase cutting-edge industry innovations and insights alongside scientific content".
Redsense has invited high-profile hemodialysis physicians Dr.
"It is an exceptional opportunity to have two physicians of this caliber presenting their data supporting the importance of improving safety in hemodialysis and doing so highlighting both the angle of instilling confidence in patients and as such empowering self-care, as well as underlying structural questions as reporting incidents, awareness and education, and reimbursement." says Sebastien Bollue, COO of
The abstract of the presentation:
Venous needle dislodgment (or central venous catheter port disconnection) during hemodialysis sessions may lead to significant or even catastrophic blood loss, particularly during unsupervised therapies. Our symposium aims to illustrate the scope of this important safety concern and to provide a systematic review of the present mitigation strategies. Through iterative and usability design, the Redsense vascular access clamp device is developed with the aim to provide additional safety to dialysis without excessive intrusion. Through our presentations and interactive demonstration, we hope to address the aforementioned learning objectives. Our symposium is intended for all dialysis providers and stakeholders.
For more details about the presentation: https://era-apps.m-anage.com/era24/en-GB/pag/session/85558
For further information about the
"We look forward to participating in this premier event in the field of nephrology with visitors from all of the world. This
Contact information
For more information, please contact:
Pontus Nobréus, CEO
Telephone: +46 72-171 1264
E-mail: pontus.nobreus (at) redsensemedical.com
ABOUT
https://news.cision.com/redsense/r/redsense-medical-spotlight-presentation-at-the-61-st--era-congress-in-stockholm,c3977633
(c) 2024 Cision. All rights reserved., source